Cargando…

Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials

BACKGROUND: We assessed the effectiveness of dual antiplatelet therapy (DAPT) post elective or urgent (i.e., post acute coronary syndrome [ACS]) coronary artery bypass graft surgery (CABG). METHODS: We systematically searched MEDLINE, EMBASE, and the Cochrane Registry from inception to August 2015....

Descripción completa

Detalles Bibliográficos
Autores principales:	Verma, Subodh, Goodman, Shaun G., Mehta, Shamir R., Latter, David A., Ruel, Marc, Gupta, Milan, Yanagawa, Bobby, Al-Omran, Mohammed, Gupta, Nandini, Teoh, Hwee, Friedrich, Jan O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605093/ https://www.ncbi.nlm.nih.gov/pubmed/26467661 http://dx.doi.org/10.1186/s12893-015-0096-z

Ejemplares similares

Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials
por: Verma, Subodh, et al.
Publicado: (2015)

Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy
por: Reid, Christopher, et al.
Publicado: (2020)

Antiplatelet therapy and coronary artery bypass grafting: Protocol for a systematic review and network meta-analysis
por: Gupta, Saurabh, et al.
Publicado: (2019)

Dual antiplatelet treatment after coronary artery bypass surgery
por: Lopez Menendez, Jose, et al.
Publicado: (2015)

Predictors of mitral valve haemodynamics after mitral valve repair for degenerative mitral regurgitation
por: Rumman, Rawan K, et al.
Publicado: (2023)

Role of Endothelium in Doxorubicin-Induced Cardiomyopathy
por: Luu, Albert Z., et al.
Publicado: (2018)

Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes: Translational Insights Into the Prevention of Ischemic Complications in Diabetes
por: Terenzi, Daniella C., et al.
Publicado: (2018)

Endothelial cell control of thrombosis
por: Yau, Jonathan W., et al.
Publicado: (2015)

Subclinical Valve Thrombosis in Sutureless Bioprosthetic Valves
por: Yanagawa, Bobby, et al.
Publicado: (2017)

Palliative Surgical Resection of an Extensive Metastatic Cardiac Myxofibrosarcoma
por: Karangelis, Dimos, et al.
Publicado: (2019)

Safety Comparison of Monotherapy Aspirin to Dual Antiplatelet Therapy Following Coronary Artery Bypass Surgery
por: Nei, Scott D., et al.
Publicado: (2022)

The Impact of Statins on Postdischarge Atrial Fibrillation After Cardiac Surgery: Secondary Analysis from a Randomized Trial
por: Hibino, Makoto, et al.
Publicado: (2022)

Investigation of TGFβ1-Induced Long Noncoding RNAs in Endothelial Cells
por: Singh, Krishna K., et al.
Publicado: (2016)

Should Antiplatelet Therapy Be Held Perioperatively? The First Study Examining Outcomes in Patients Receiving Dual Antiplatelet Therapy in the Lower Extremity Free Flap Population
por: Bekeny, Jenna C., et al.
Publicado: (2020)

Dual Antiplatelet Therapy before Coronary Artery Bypass Grafting; a Systematic Review and Meta-Analysis
por: Sadeghi, Roxana, et al.
Publicado: (2020)

The impact of dual antiplatelet therapy administration on the risk of bleeding complications during coronary artery bypass surgery
por: Nardi, Paolo, et al.
Publicado: (2021)

Frailty and pre-frailty in cardiac surgery: a systematic review and meta-analysis of 66,448 patients
por: Lee, Jessica Avery, et al.
Publicado: (2021)

Isolation and characterization of circulating pro-vascular progenitor cell subsets from human whole blood samples
por: Terenzi, Daniella C., et al.
Publicado: (2021)

Implications of the Antiplatelet Therapy Gap Left With Discontinuation of Prasugrel in Canada
por: Lordkipanidzé, Marie, et al.
Publicado: (2020)

Should C-Reactive Protein Be a Target of Therapy?
por: Oh, Jisun, et al.
Publicado: (2011)

Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study
por: Yan, Hua, et al.
Publicado: (2020)

Dual antiplatelet therapy up to the time of non-elective coronary artery bypass grafting with prophylactic platelet transfusion: is it safe?
por: Charif, Fida, et al.
Publicado: (2019)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)

Dual antiplatelet therapy before coronary artery bypass grafting in patients with myocardial infarction: a prospective cohort study
por: Sadeghi, Roxana, et al.
Publicado: (2021)

Canagliflozin Improves the Recovery of Blood Flow in an Experimental Model of Severe Limb Ischemia
por: Sherman, Stephen E., et al.
Publicado: (2018)

BRCA1 is an essential regulator of heart function and survival following myocardial infarction
por: Shukla, Praphulla C., et al.
Publicado: (2011)

Should We Be Afraid of Antiplatelet Treatment before Carotid Endarterectomy?
por: Sucu, Nehir, et al.
Publicado: (2018)

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
por: Muthspiel, Marie, et al.
Publicado: (2022)

Injection Drug Use Endocarditis: An Inner-City Hospital Experience
por: Syed, Ishba M., et al.
Publicado: (2021)

Is the use of dual antiplatelet therapy following urgent and emergency coronary artery bypass surgery associated with increased risk of cardiac tamponade?
por: Hussain, Azar, et al.
Publicado: (2021)

Dual Antiplatelet Therapy in Coronary Artery Disease
por: Sharma, Raghav, et al.
Publicado: (2020)

Should A1C Targets Be Individualized for All People With Diabetes?: Arguments for and against
por: Teoh, Hwee, et al.
Publicado: (2011)

Loss of endothelial cell-specific autophagy-related protein 7 exacerbates doxorubicin-induced cardiotoxicity
por: Luu, Albert Z., et al.
Publicado: (2021)

Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent
por: Huseynov, Aydin, et al.
Publicado: (2019)

Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery: A Randomized Clinical Trial
por: Ha, Andrew C. T., et al.
Publicado: (2021)

Ticagrelor: An emerging oral antiplatelet agent
por: Juneja, Shivani, et al.
Publicado: (2013)

Cardiovascular Safety of Celecoxib on Top of Dual Antiplatelet Therapy
por: Hong, Bum-Kee
Publicado: (2010)

Dental extraction in patients receiving dual antiplatelet therapy
por: Sánchez-Palomino, Paulino, et al.
Publicado: (2015)

Surgical tracheotomy performed with and without dual antiplatelet therapy
por: Markota, Andrej, et al.
Publicado: (2014)

Duration of dual antiplatelet therapy in acute coronary syndrome
por: Wilson, Simon John, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rao912hkh0ns3jd59r7spqqg2q